NYSE · UNH
UnitedHealth Group Incorporated
$410.91+$3.81 (+0.94%)
UnitedHealth Group Incorporated’s quoted price sits in the upper half of its reported 52-week range, 10.99% below the high.
Loading market information…
NYSE · CNC · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Centene Corp.’s quoted price sits in the upper half of its reported 52-week range, 5.35% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Centene Corp.’s next earnings report is currently expected on Feb 5, 2027, with estimated earnings per share of -$1.12. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Centene Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:09 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q2 2025 |
|---|
| Jul 25, 2025 |
| -$0.16-243.37% vs estimate |
| $48.74B+10.44% vs estimate |
| Q1 2025 | Apr 25, 2025 | $2.90+15.08% vs estimate | $46.62B+9.03% vs estimate |
|---|
| Q4 2024 | Feb 4, 2025 | $0.80+81.82% vs estimate | $40.81B+3.67% vs estimate |
|---|
THE ANALYST VIEW
44 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 14 contributors · Median target $78.50.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$410.91+$3.81 (+0.94%)
UnitedHealth Group Incorporated’s quoted price sits in the upper half of its reported 52-week range, 10.99% below the high.
$90.33+$0.38 (+0.42%)
CVS Health Corp.’s quoted price sits in the upper half of its reported 52-week range, 18.39% below the high.
$422.02+$7.61 (+1.84%)
Elevance Health Inc.’s quoted price sits in the upper half of its reported 52-week range, 6.36% below the high.
$298.41+$3.41 (+1.16%)
Cigna Corporation’s quoted price sits in the upper half of its reported 52-week range, 5.65% below the high.
$417.56+$5.69 (+1.38%)
Humana Inc.’s quoted price sits in the upper half of its reported 52-week range, 8.53% below the high.
$198.95+$0.85 (+0.43%)
Molina Healthcare, Inc.’s quoted price sits in the upper half of its reported 52-week range, 18.76% below the high.
R$14.77-R$0.01 (-0.07%)
Bradsaude S.A.’s quoted price sits in the upper half of its reported 52-week range, 10.86% below the high.
$30.79+$0.31 (+1.02%)
Oscar Health, Inc.’s quoted price sits in the upper half of its reported 52-week range, 12.05% below the high.
